New trends of progestins treatment of endometriosis

Gynecological Endocrinology

Volumn 30, Issue 11, 2014, Pages 769-773

  Angioni, Stefano ^a   Cofelice, Vito ^a   Pontis, Alessandro ^a   Tinelli, Raffaele ^b   Socolov, Razvan ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UOC Ostetricia e Ginecologia Ospedale San Bassiano   (Italy)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Chronic pain; Dienogest; Endometriosis; Etonorgestel; Levonorgestrel; Progestins

Indexed keywords

DIENOGEST; ETONOGESTREL; GESTAGEN; LEVONORGESTREL;

ARTICLE; ENDOMETRIOSIS; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL INTRAUTERINE DEVICE; FEMALE; TREATMENT OUTCOME;

ENDOMETRIOSIS; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; PROGESTINS; TREATMENT OUTCOME;

EID: 84910073670     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.950646     Document Type: Article

References (38)

1. Locci R, Nisolle M, Angioni S, et al. Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis. Reprod Biol Endocrinol 2013;11:94.
2. Jones CJ, Inuwa IM, Nardo LG, et al. Eutopic endometrium from women with endometriosis shows altered ultrastructure and glycosylation compared to that from healthy controls - a pilot observational study. Reprod Sci 2009;16:559-72.
3. Melis I, Agus M, Pluchino N, et al. Alexithymia in women with deep endometriosis? A pilot study. J Endometriosis Pelvic Pain Dis 2014; 6:26-33.
4. Melis GB, Guerriero S, Paoletti AM, et al. Diagnosis of endometriosis. Giornale Italiano di Ginecologia e Ostetricia 2005; 27:293-6.
5. Socolov R, Butureanu S, Angioni S, et al. The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. Eur J Obstet Gynecol Reprod Biol 2011;154:215-17.
6. Angioni S, Peiretti M, Zirone M, et al. Laparoscopic excision of posterior vaginal fornix in the treatment of patients with deep endometriosis without bowel involvement: surgical treatment and long term follow-up. Hum Reprod 2006;21:1629-34.
7. Angioni S, Maricosu G, Mereu L, et al. Single Port Access Laparoscopy (SPAL) for endometrioma excision. J Endometriosis Pelvic Pain Dis 2010;2:95-8.
8. Pisanu A, Deplano D, Angioni S, et al. Rectal perforation from endometriosis in pregnancy: case report and literature review. World J Gastroenterol 2010;16:648-51.
9. Rizzo A, Spedicato M, Mutinati M, et al. Peritoneal adhesions in human and veterinary medicine: from pathogenesis to therapy: a review. Immunopharmacol Immunotoxicol 2010;32:481-94.
10. Litta, P, D'Agostino G, Conte L, et al. Müllerian hormone trend after laparoscopic surgery in women with ovarian endometrioma. Gynecol Endocrinol 2013;29:452-4.
11. Vercellini P, Fedele L, Aimi G, et al. Reproductive performance, pain recurrenceand disease relapse after conservative surgical treatment for endometriosis: the predictive value of current system. Hum Reprod 2006;21:2679-85.
12. Vercellini P, De Giorgi O, Mosconi P, et al. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002; 77:52-61.
13. Muneyyirci-Delale O, Karacan M. Effect of norethindrone acetate in the treatment of symptomatic endometriosis. Int J Fertil Women Med 1998;43:24-7.
14. Harrison RF, Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril 2000;74:24-30.
15. Gomes MK, Rosa e Silva JC. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009;24:2736-745.
16. Abou-Setta AM, Houston B, Al-Inany HG, et al. Levonorgestrelreleasing intrauterine device (LNG - IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013;1:CD005072.
17. Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-administrated progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of disease. Hum Reprod 2004;1:179-84.
18. Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 2005;20:789-93.
19. Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993-8.
20. Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003;80:305-9.
21. Lan S, Ling L, Zhao J, et al. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis. J Inte Med Res 2013; 41:548-58.
22. Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrelreleasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485-8.
23. Wenzl R, van Beek A, Schnabel P, et al. Pharmacogenetics of etonogestrel released from the contraceptive implant Implanon. Contraception 1998;58:283-8.
24. Walch K, Unfried G, Huber J, et al. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis - a pilot study. Contraception 2009;79:29-34.
25. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 1998;58:99S-107S.
26. Xiangyan R, Seeger H, Mueck AO. The pharmacology of dienogest. Maturitas 2012;71:337-44.
27. Oettel M, Graser T, Hoffman H. Why dienogest as a progestogenic component of the postmenopausal nonandrogenic hormone replacement therapy. Drugs Today 2001;37:3-15.
28. Kohler G, Faustmann TA, Gerlinger C, et al. A dose ranging study to determine the efficacy and safety of 1, 2 and 4mg of dienogest daily for endometriosis. Int J Gynaecol Obstet 2010;108:21-5.
29. Momoeda M, Taketani Y. A randomized, double-blind, multicenter, parallelel, dose-response study of dienogest in patients with endometriosis [article in Japanese]. J Pharmacol Ther 2007;35: 769-83.
30. Strowitzki T, Faustmann T, Gerlinger C, et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynaecol Reprod Biol 2010;151:193-8.
31. Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 2012; 285:167-73.
32. Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25:633-41.
33. Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis: a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009;91:675-81.
34. Cosson M, Queleu D, Donnez J, et al. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril 2002;77:684-92.
35. Schindler AE, Henkel A, Moore C, et al. Effect and safety of high dose dienogest (20 mg/day) in the treatment of women with endometriosis. Arch Gynecol Obstet 2010;282:507-14.
36. Artini PG, Volpe A, Angioni S, et al. A comparative randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 1995; 18:57-62.
37. Florio P, Imperatore A, Litta P, et al. The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women. Steroids 2010;75:912-17.
38. Pluchino N, Cubeddu A, Giannini A, et al. Progestogens and brain: an update. Maturitas 2009;62:349-55.